Alzheimer's-slowing drug Leqembi gains full FDA approval

The medication should be widely covered by Medicare.

Related Keywords

United States ,Japan ,Japanese ,Americans ,Sanjeev Vaishnavi ,Penn Memory Center ,Research Teresa Buracchio ,Drug Administration ,Office Of Neuroscience ,United States Based ,Drug Evaluation ,Alzheimers Disease ,Food And Drug Administration ,Drug Targeting ,Regulatory Approval ,Disease Progression ,Leqembi ,Grain Protein ,